Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on ...

The case involved a clinical trial of Akero's only product, a drug candidate aimed at treating a liver disease. It's the ...

Equifax® (NYSE: EFX) today announced that the Equifax Board of Directors declared a quarterly dividend of $0.50 per share, payable on September 15, 2025, to shareholders of record as of the close of ...

Equifax faces growth headwinds, premium valuation, and flat price action despite AI and cloud investments, with limited ...

Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with ...

EVTC sticks out from EFX in both our Zacks Rank and Style Scores models, so value investors will likely feel that EVTC is the better option right now. To read this article on Zacks.com click here.